Aquafil S.p.A (ECNL) Fair Value & Analysis
Consumer Cyclical · IT · Market cap €123M
Fair value as of: Jun 25, 2026
Analysis
Aquafil S.p.A (ECNL) currently trades at €1.36, while our model-based Fair Value estimate is €3.39 — implying the stock looks roughly 148.5% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Aquafil S.p.A., together with its subsidiaries, engages in the production, reprocessing, and sale of yarns in Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company offers bulk continuous filament for textile floor covering, such as polyamide 6-based yarn, partly petroleum-based, and partly from regenerated ECONYL; nylon textile filament fibers for textile and clothing use, including polyamide 6 and 66 fibers, and Dryarn polypropylene microfibers for men's and women's hosiery, as well as knitwear and non-run fabrics for underwear, sportswear, and special technical applications; and polymers and polyamide 6 for engineering plastics and injection molding. It is also involved in industrial chemical plant design and supply. The company was founded in 1965 and is headquartered in Arco, Italy. Aquafil S.p.A. operates as a subsidiary of Aquafin Holding S.p.A.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Aquafil S.p.A (ECNL) undervalued?
What is the fair value of ECNL?
What is the quality score of ECNL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.